Target intelligence / Profile preview

Poliovirus Antigens (Types 1-3)

Molecular classification
Viral capsid protein, Antigen
01

Overview

Poliovirus antigens refer to the structural proteins and epitopes present on the surface of polioviruses, which are recognized by the immune system. There are three serotypes of poliovirus—Type 1 (PV-1), Type 2 (PV-2), and Type 3 (PV-3)—each defined by distinct antigenic properties primarily determined by differences in their capsid proteins. These antigens are critical for both natural immunity following infection and vaccine-induced protection. The major antigenic sites are located on the capsid proteins VP1, VP2 and VP3. Neutralizing antibodies against these antigenic sites confer immunity to specific poliovirus types. Immunity to one serotype does not guarantee protection against others due to significant antigenic differences among them—hence vaccines include all three types to ensure broad coverage. The cellular receptor used by all three poliovirus types is known as Pvr or CD155—a cell adhesion molecule that mediates virus entry into host cells. Capsid protein variations among the serotypes determine their receptor binding specificity and thus their unique antigenicity.

Other names
PV-1 antigensPV-2 antigensPV-3 antigensPoliovirus capsid proteinsVP1VP2VP3VP4
02

Mechanism of action

Vaccine-induced neutralizing antibody production

03

Biological functions

Viral entryImmune recognitionAntigen presentationReceptor binding
04

Disease associations

PoliomyelitisViral infection
05

Safety considerations

Vaccine-derived poliovirus (VDPV) in OPVImmune response variability
06

Interacting drugs

Oral Polio Vaccine (OPV)

1 more in the full profile.

07

Biomarkers

Neutralizing antibody titers against PV-1Neutralizing antibody titers against PV-2Neutralizing antibody titers against PV-3

Beyond the preview

Go deeper on Poliovirus Antigens (Types 1-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus Antigens (Types 1-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call